Faruqi & Faruqi To Lead Teva Securities Suit Over Kickbacks
Law360 (March 26, 2021, 10:38 PM EDT) -- Faruqi & Faruqi LLP was selected Friday to helm a putative investor class alleging that Teva Pharmaceuticals lied about illegal kickback payments it made to charitable foundations to cover Medicare copayments of patients taking its multiple sclerosis drug, according to an order filed in Pennsylvania federal court.
The firm beat out Pomerantz LLP for the spot, according to the case docket.
In their proposed class action, the investors said that Teva made false and misleading statements about why the drug, Copaxone, saw such commercial success. Notably, the company failed to disclose that it was coordinating with nonprofits Chronic Disease Fund and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!